Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M405335200 on July 12, 2004

J. Biol. Chem., Vol. 279, Issue 37, 38386-38394, September 10, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/37/38386    most recent
M405335200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wietfeld, D.
Right arrow Articles by Berger, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wietfeld, D.
Right arrow Articles by Berger, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Regulation of the Coupling to Different G Proteins of Rat Corticotropin-releasing Factor Receptor Type 1 in Human Embryonic Kidney 293 Cells*

Doreen Wietfeld, Nadja Heinrich, Jens Furkert, Klaus Fechner, Michael Beyermann, Michael Bienert, and Hartmut Berger{ddagger}

From the Institute of Molecular Pharmacology, Robert-Rössle-Strasse 10, Berlin 13125, Germany

The regulation of G protein activation by the rat corticotropin-releasing factor receptor type 1 (rCRFR1) in human embryonic kidney (HEK)293 (HEK-rCRFR1) cell membranes was studied. Corresponding to a high and low affinity ligand binding site, sauvagine and other peptidic CRFR1 ligands evoked high and low potency responses of G protein activation, differing by 64-fold in their EC50 values as measured by stimulation of [35S]GTP{gamma}S binding. Contrary to the low potency response, the high potency response was of lower GTP{gamma}S affinity, pertussis toxin (PTX)-insensitive, and homologously desensitized. Distinct desensitization was also observed in the adenylate cyclase activity, when its high potency stimulation was abolished and the activity became low potently inhibited by sauvagine. From these results and immunoprecipitation of [35S]GTP{gamma}S-bound G{alpha}s and G{alpha}i subunits it is concluded that the high and low potency [35S]GTP{gamma}S binding stimulation reflected coupling to Gs and Gi proteins, respectively, only Gs coupling being homologously desensitized. Immunoprecipitation of [35S]GTP{gamma}S-bound G{alpha}q/11 revealed additional coupling to Gq/11, which also was homologously desensitized. Although G{alpha}q/11 coupling was PTX-insensitive, half of the sauvagine-stimulated accumulation of inositol phosphates in the cells was PTX-sensitive, suggesting involvement of Gi in addition to Gq/11in the stimulation of inositol metabolism. It is concluded that CRFR1 signals through at least two different ways, one leading to Gs- and Gq/11-mediated signaling steps and desensitization and another leading to Gi -mediated signals without being desensitized. Furthermore, the concentrations of the stimulating ligand and GTP and desensitization may be part of a regulatory mechanism determining the actual ratio of the coupling of CRFR1 to different G proteins.


Received for publication, May 13, 2004 , and in revised form, July 1, 2004.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed. Tel.: 49-30-94793-273; Fax: 49-30-94793-159; E-mail: berger{at}fmp-berlin.de.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. Alken, A. Schmidt, C. Rutz, J. Furkert, G. Kleinau, W. Rosenthal, and R. Schulein
The Sequence after the Signal Peptide of the G Protein-Coupled Endothelin B Receptor Is Required for Efficient Translocon Gating at the Endoplasmic Reticulum Membrane
Mol. Pharmacol., April 1, 2009; 75(4): 801 - 811.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. F. Mesleh, W. A. Shirley, C. E. Heise, N. Ling, R. A. Maki, and R. P. Laura
NMR Structural Characterization of a Minimal Peptide Antagonist Bound to the Extracellular Domain of the Corticotropin-releasing Factor1 Receptor
J. Biol. Chem., March 2, 2007; 282(9): 6338 - 6346.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Rutz, A. Renner, M. Alken, K. Schulz, M. Beyermann, B. Wiesner, W. Rosenthal, and R. Schulein
The Corticotropin-releasing Factor Receptor Type 2a Contains an N-terminal Pseudo Signal Peptide
J. Biol. Chem., August 25, 2006; 281(34): 24910 - 24921.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
E. W. Hillhouse and D. K. Grammatopoulos
The Molecular Mechanisms Underlying the Regulation of the Biological Activity of Corticotropin-Releasing Hormone Receptors: Implications for Physiology and Pathophysiology
Endocr. Rev., May 1, 2006; 27(3): 260 - 286.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement